The HCPLive insomnia page is a comprehensive resource for clinical news and insights on sleeplessness. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for insomnia, and more.
Non-Pharmacologic Management of Insomnia in the Elderly
Consequences of Poor Sleep in the Elderly
Prevalence of Insomnia Disorder With Age
Defining and Diagnosing Insomnia Disorder
Obstructive Sleep Apnea Subtypes Linked to Cardiovascular Event Risks
Clinicians have indicated which symptom subtypes are associated with a greater risk of cardiovascular conditions in patients with OSA.
FDA Issues CLR for Tasimelteon to Treat Jet Lag Disorder
Vanda CEO expressed disappointment after FDA fails to approve jet lag disorder treatment due to unclear clinical significance.
Karl Doghramji, MD: Diagnostic Protocol for Sleep Conditions
What criteria should physicians follow to properly diagnose insomnia and its many comorbid conditions in older patients?
FDA Approves Drug to Treat Excessive Daytime Sleepiness for Narcolepsy Patients
The approval marks the first ever treatment for patients with narcolepsy that is not scheduled as a controlled substance by the DEA.
Karl Doghramji, MD: Comorbidities Driving Insomnia
Multiple conditions, especially those common in the elderly, can greatly increase the risk of insomnia.
Karl Doghramji, MD: Insomnia Distinctions
A clinical breakdown of what constitutes primary, secondary, chronic, and acute forms of insomnia.
Oral Appliance Treatment More Effective for OSA Patient with Certain Traits
OSA patients with certain traits experienced a 73% reduction in AHI events from oral appliance treatment.
Karl Doghramji, MD: Elderly Insomnia Drivers
As patients age, they become more susceptible to the cyclical factors that can drive insomnia severity.
Karl Doghramji, MD: Defining Insomnia
What are the symptoms and patient complaints that comprise the common sleep disorder?
Transcutaneous Vagal Nerve Stimulation Helps Older Adults Function
Just 2 weeks of therapy could help attenuated autonomic function for geriatric adults.
FDA Clears At-Home Sleep Apnea Monitoring Device
The prescription device can monitor and share reports on patient's sleep breathing patterns, leading to accurate symptom diagnoses.
Study Links Obstructive Sleep Apnea With Major Depression
New research finds association common sleep disorder present in 14% of suicidal patients with major depressive disorder studied.
Obstructive Sleep Apnea Could Affect Nearly 1 Billion Globally
A new assessment of prevalence studies shows some countries could have an OSA prevalence rate of more than half their entire population.
Going The Distance: The Impact of Sports Medicine on Primary Care
An all-star team of physicians give their takes on how the science behind keeping million dollar athletes on the field has impacted the care patients receive every day.
CPAP-Treated Sleep Apnea Linked to Diabetes Risk Reduction
A new retrospective cohort finds that patients with untreated obstructive sleep apnea face a two-fold greater risk of developing T2D.
Lemborexant Shows Promise for Sleep Disorders
Experimental drug lemborexant underwent several phase 3 studies presented at the annual SLEEP 2019 meeting.
Sleep Disorders Common Among Nurses
A survey of nurses at an academic medical center found that 49% averaged less than 7 hours of sleep per night, compared to the national figure of 28%.
Marta Kaminska, MD: Linking Poor Sleep and COPD Condition
New findings better evidence the link between long-term COPD exacerbations and poor patient sleep quality. How well-understood is the association between sleep and pulmonary conditions?
Why Physicians Need to Ask Patients About Sleep
Sleep habits are an overlooked aspect of primary care visits, despite the prevalence and burden of conditions such like insomnia on the general population.
Robert Bober, MD: Results of the Optimal Hospital Innovations
By applying research-supported practices, Optimal Hospital has increased patient sleep, improved HCAHPS scores, and decreased length of stay and readmissions.
FDA Accepts NDA for Investigational Insomnia Drug Lemborexant
An FDA decision on the application is expected by December 27, 2019.
Investigational Insomnia Drug Yields Positive Results in Phase 3 Updates
The investigational agent being developed for the sleep-wake disorder demonstrated statistically significant improvements in the 6-month results.
Cardiovascular Disease Is Present in Nearly 50% of US Adults
According to updated statistics form the American Heart Association (AHA), cardiovascular disease is present in approximately 50% of US adults.
Hepatitis C Analysis Yields Insights into Chronic Fatigue Development
Researchers studied patients with hepatitis C in order to find out the relationship between immune activation and chronic fatigue.
Poor Sleep Habits Linked with Risky Sexual Behavior in HIV-Susceptible Population
Men who don’t get much sleep also tend to make poor sexual decisions when it comes to HIV prevention, a new study suggests.
Insomnia Linked to Increased Risk of Developing AMD
A population-based cohort study identified that patients with insomnia developed AMD at a rate 0.7% higher than those who did not.